Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
| Website: | www.amgen.com |
| Email: | investor.relations@amgen.com |
| Main Phone: | +1 805 447-1000 |
| Address: | One Amgen Center Drive |
| Address 2: | Suite 2650 |
| State: | CA |
| City / Town: | Thousand Oaks |
| Country: | USA |
| Postal Code: | 91320-1799 |
| Exchange: | NGS |
| CEO: | Robert A. Bradway |
| Employees: | 20800 |
| NAICS: | Biological Product (except Diagnostic) Manufacturing(325414) |
| Last Price 205.10 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid 204.84 | Bid Size 100.00 | Ask 206.50 | Ask Size 100.00 |
| Open 205.66 | High 206.62 | Low 204.17 | Prev Close 205.10 |
| Last Trade | Volume 7.3 mi | 52 Wk Hi 206.62 | 52 Wk Low 163.31 |
| Market Cap 132.8 bi | Ex-Div Date | Div Rate 5.28 | Yield 2.5740 |
| Shares 647,272,067.00 | EPS (TTM) 3.72 | PE Ratio 55.10 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 45 | 74 |
| Number of Buys | 23 | 31 |
| Number of Sells | 22 | 43 |
| Net Activity | -8304 | 75103 |
| Last 10 Buys | Shares |
|---|---|
| Fred Hassan | 1,000 |
| Fred Hassan | 1,000 |
| Frank C. Herringer | 1,000 |
| Frank C. Herringer | 1,000 |
| Robert A. Bradway | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| Sean Harper | 1,000 |
| De Francois Carbonnel | 1,000 |
| Sean Harper | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 224 | 224 | 224 | 224 |
| Low Target Price Estimate | 165 | 165 | 165 | 165 |
| Mean Target Price Estimate | 193.94 | 193.94 | 193.12 | 193.94 |
| Standard Deviation | 15.01 | 15.01 | 14.92 | 15.01 |
| Date of Most Recent Estimate | 06/03/18 | 05/22/18 | 05/22/18 | 06/03/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| CT ORDER | 1 | 2018-05-30 | |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-22 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-05-22 |
| CT ORDER | 1 | 2018-05-17 | |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 12 | 13 | 14 | 14 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.22 | 2.26 | 2.3 | 2.3 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
